Keyphrases
Phosphorylation
100%
Vascular Endothelial Growth Factor
100%
Endothelial Nitric Oxide Synthase (eNOS)
100%
Isoflurane
100%
Cardiac Preconditioning
100%
Nitric Oxide
28%
Endothelial Cells
28%
Hypoxia-inducible factor-1α (HIF-1α)
28%
Cardiomyocytes
28%
Short Hairpin RNA (shRNA)
28%
Neutralizing Antibodies
28%
Nitric Oxide Production
28%
Recombinant
14%
Western Blot
14%
Ischemia-reperfusion Injury
14%
Reperfusion
14%
Protective Effect
14%
Negative Effects
14%
Beneficial Effects
14%
Wistar Rats
14%
Anesthetics
14%
Phosphorylated Endothelial Nitric Oxide Synthase
14%
Volatile Anesthetics
14%
Lactate Dehydrogenase Activity
14%
Myocardial Infarct Size
14%
Coronary Artery Occlusion
14%
Hypoxia-reoxygenation
14%
Cultured Cardiomyocytes
14%
Chemiluminescence
14%
Coronary Artery Endothelial Cells
14%
Hypoxia Injury
14%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin
100%
Endothelial Nitric Oxide Synthase
100%
Isoflurane
100%
Nitric Oxide
57%
Hypoxia
28%
Short Hairpin RNA
28%
Hypoxia Inducible Factor 1
28%
Neutralizing Antibody
28%
Western Blot
14%
Wistar Rat
14%
Injury
14%
Heart Infarction
14%
Ischemia
14%
Inhalation Anesthetic Agent
14%
Coronary Artery Occlusion
14%
Recombinant Vasculotropin
14%
Lactate Dehydrogenase
14%
Biochemistry, Genetics and Molecular Biology
Isoflurane
100%
Vascular Endothelial Growth Factor
100%
Nitric Oxide Synthase
100%
Nitric Oxide
50%
Cardiac Muscle Cell
37%
Reperfusion
25%
Hypoxia Inducible Factor 1
25%
Reoxygenation
25%
Small Hairpin RNA
25%
Neutralizing Antibody
25%
Chemoluminescence
12%
Mediator
12%
Wistar Rat
12%
Lactate Dehydrogenase
12%
Western Blotting
12%
Immunology and Microbiology
Vasculotropin
100%
Cardiac Muscle Cell
42%
Neutralizing Antibody
28%
Reperfusion
28%
Hypoxia Inducible Factor 1
28%
Reoxygenation
28%
Western Blot
14%
Mediator
14%
Coronary Artery
14%
Chemoluminescence
14%
Wistar Rat
14%
Recombinant Vasculotropin
14%